Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/25145
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMorozova, O.-
dc.contributor.authorMakieieva, N.-
dc.date.accessioned2019-12-01T17:15:18Z-
dc.date.available2019-12-01T17:15:18Z-
dc.date.issued2019-
dc.identifier.citationMorozova O. TGF-β1 and VEGF as biomarkers for renal scarring in children with vesicoureteral reflux / O. Morozova, N. Makieieva // Nephrology Dialysis Transplantation. ‒ 2019. ‒ Vol. 34, Issue Suppl. 1 : 56-th ERA-EDTA Congress, Hungary, 13‒16 June 2019. ‒ FP812. ‒ DOI: https://doi.org/10.1093/ndt/gfz106.FP812.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/25145-
dc.description.abstractOne of the most common forms of congenital obstructive uropathy in children is vesicoureteral reflux (VUR), which is observed in 1-2% of pediatric population, and its incidence in urinary tract infection is 70%. According to the International Committee for the Study of Reflux, the incidence of nephrosclerosis in VUR among children of the European population is 48% and it results in the development of the terminal stage of chronic renal failure in 25-60% of patients. Approximately 25% of children with renal scarring (RS) caused by VUR require hemodialysis and kidney transplantation.ru_RU
dc.language.isoenru_RU
dc.subjectchronic kidney diseaseru_RU
dc.subjectchildrenru_RU
dc.titleTGF-β1 and VEGF as biomarkers for renal scarring in children with vesicoureteral refluxru_RU
dc.typeArticleru_RU
Appears in Collections:Наукові праці. Кафедра педіатрії № 2

Files in This Item:
File Description SizeFormat 
тези Морозова Будапешт.pdf85,99 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.